Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q58020832)
Watch
English
Hepatocellular carcinoma
scientific article published on 05 January 2018
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
29307467
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29307467%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 April 2020
title
Hepatocellular carcinoma
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
29307467
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29307467%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 April 2020
author
Alejandro Forner
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
29307467
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29307467%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 April 2020
María Reig
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed publication ID
29307467
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29307467%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 April 2020
Jordi Bruix
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed publication ID
29307467
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29307467%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 April 2020
Alejandro Forner
series ordinal
1
object named as
Alejandro Forner
0 references
Jordi Bruix
series ordinal
3
object named as
Jordi Bruix
0 references
María Reig
series ordinal
2
object named as
María Reig
0 references
language of work or name
English
0 references
publication date
5 January 2018
1 reference
stated in
Europe PubMed Central
PubMed publication ID
29307467
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29307467%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 April 2020
published in
The Lancet
1 reference
stated in
Europe PubMed Central
PubMed publication ID
29307467
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29307467%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 April 2020
volume
391
1 reference
stated in
Europe PubMed Central
PubMed publication ID
29307467
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29307467%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 April 2020
issue
10127
1 reference
stated in
Europe PubMed Central
PubMed publication ID
29307467
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29307467%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 April 2020
page(s)
1301-1314
1 reference
stated in
Europe PubMed Central
PubMed publication ID
29307467
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29307467%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 April 2020
cites work
Hepatocellular carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Epidemiology of viral hepatitis and hepatocellular carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Carriers of inactive hepatitis B virus are still at risk for hepatocellular carcinoma and liver-related death
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Alcohol and hepatocellular carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A Joinpoint regression analysis of long-term trends in cancer mortality in Japan (1958-2004)
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Global trends and predictions in hepatocellular carcinoma mortality
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hepatocellular cancer: the impact of obesity, type 2 diabetes and a multidisciplinary team
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Trends in the Burden of Nonalcoholic Fatty Liver Disease in a United States Cohort of Veterans
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Distinctive features of hepatocellular carcinoma in non-alcoholic fatty liver disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Diabetes mellitus, insulin treatment, diabetes duration, and risk of biliary tract cancer and hepatocellular carcinoma in a European cohort
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Alcohol, tobacco and obesity are synergistic risk factors for hepatocellular carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Coffee and the risk of hepatocellular carcinoma and chronic liver disease: a systematic review and meta-analysis of prospective studies
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The prevalence of cirrhosis and hepatocellular carcinoma in patients with human immunodeficiency virus infection
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Long-term Effects of Hepatitis B Immunization of Infants in Preventing Liver Cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Risk of hepatocellular carcinoma in chronic hepatitis B: assessment and modification with current antiviral therapy.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Antiviral therapy reduces risk of hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Eradication of Hepatitis C Virus Infection and the Development of Hepatocellular Carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Liver Cancer Emergence Associated with Antiviral Treatment: An Immune Surveillance Failure?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hepatocellular carcinoma risk following direct-acting antiviral HCV therapy: A systematic review, meta-analyses, and meta-regression
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Index-based dietary patterns and risk of incident hepatocellular carcinoma and mortality from chronic liver disease in a prospective study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Metformin decreases hepatocellular carcinoma risk in a dose-dependent manner: population-based and in vitro studies
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of long-term propranolol treatment on hepatocellular carcinoma incidence in patients with HCV-associated cirrhosis.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Atorvastatin and fluvastatin are associated with dose-dependent reductions in cirrhosis and hepatocellular carcinoma, among patients with hepatitis C virus: Results from ERCHIVES.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Genetic profiling of hepatocellular carcinoma using next-generation sequencing.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Surveillance for hepatocellular carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Principles of cancer screening: lessons from history and study design issues
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomized controlled trial of screening for hepatocellular carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Feasibility of conducting a randomized control trial for liver cancer screening: is a randomized controlled trial for liver cancer screening feasible or still needed?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Mailed Outreach Program Increases Ultrasound Screening of Patients With Cirrhosis for Hepatocellular Carcinoma.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cost-effectiveness of screening for detection of small hepatocellular carcinoma in western patients with Child-Pugh class A cirrhosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Management of hepatocellular carcinoma: An update
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Meta-analysis: surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Detection of hepatocellular carcinoma at advanced stages among patients in the HALT-C trial: where did surveillance fail?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Alpha-fetoprotein, des-gamma carboxyprothrombin, and lectin-bound alpha-fetoprotein in early hepatocellular carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Des-gamma-carboxy prothrombin and alpha-fetoprotein as biomarkers for the early detection of hepatocellular carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Combined alpha fetoprotein testing and ultrasonography as a screening test for primary liver cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Glypican-3: a novel serum and histochemical marker for hepatocellular carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Serum DKK1 as a protein biomarker for the diagnosis of hepatocellular carcinoma: a large-scale, multicentre study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Role of the GALAD and BALAD-2 Serologic Models in Diagnosis of Hepatocellular Carcinoma and Prediction of Survival in Patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Semiannual surveillance is superior to annual surveillance for the detection of early hepatocellular carcinoma and patient survival.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Ultrasonographic surveillance of hepatocellular carcinoma in cirrhosis: A randomized trial comparing 3- and 6-month periodicities
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Overdiagnosis in cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The diagnostic and economic impact of contrast imaging techniques in the diagnosis of small hepatocellular carcinoma in cirrhosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The impact of vascular and nonvascular findings on the noninvasive diagnosis of small hepatocellular carcinoma based on the EASL and AASLD criteria
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Optimization of imaging diagnosis of 1–2cm hepatocellular carcinoma: An analysis of diagnostic performance and resource utilization
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Non-invasive diagnosis of hepatocellular carcinoma ⩽2cm in cirrhosis. Diagnostic accuracy assessing fat, capsule and signal intensity at dynamic MRI
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
New MR imaging criteria with a diffusion-weighted sequence for the diagnosis of hepatocellular carcinoma in chronic liver diseases
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Liver Imaging Reporting and Data System with MR Imaging: Evaluation in Nodules 20 mm or Smaller Detected in Cirrhosis at Screening US.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Intrahepatic peripheral cholangiocarcinoma in cirrhosis patients may display a vascular pattern similar to hepatocellular carcinoma on contrast-enhanced ultrasound
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Patterns of appearance and risk of misdiagnosis of intrahepatic cholangiocarcinoma in cirrhosis at contrast enhanced ultrasound.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prospective validation of an immunohistochemical panel (glypican 3, heat shock protein 70 and glutamine synthetase) in liver biopsies for diagnosis of very early hepatocellular carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prognosis prediction and staging
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Development of Hong Kong Liver Cancer staging system with treatment stratification for patients with hepatocellular carcinoma.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Liver cirrhosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The ALBI grade provides objective hepatic reserve estimation across each BCLC stage of hepatocellular carcinoma.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Sorafenib in advanced hepatocellular carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Role of radiotherapy in the management of hepatocellular carcinoma: A systematic review
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Survival after yttrium-90 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona clinic liver cancer stages: a European evaluation.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Yttrium-90 radioembolization for intermediate-advanced hepatocellular carcinoma: A phase 2 study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular Carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Evidence-based Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2013 update (3rd JSH-HCC Guidelines).
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hepatic venous pressure gradient in the assessment of portal hypertension before liver resection in patients with cirrhosis.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The role of hepatic resection in the treatment of hepatocellular cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Assessment of portal hypertension by transient elastography in patients with compensated cirrhosis and potentially resectable liver tumors
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Value of transient elastography measured with FibroScan in predicting the outcome of hepatic resection for hepatocellular carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Portal hypertension and the outcome of surgery for hepatocellular carcinoma in compensated cirrhosis: a systematic review and meta-analysis.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Radiofrequency ablation for hepatocellular carcinoma: 10-year outcome and prognostic factors.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Survival comparison between surgical resection and radiofrequency ablation for patients in BCLC very early/early stage hepatocellular carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Superselective transarterial chemoembolization for hepatocellular carcinoma. Validation of treatment algorithm proposed by Japanese guidelines.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Survival of patients with hepatocellular carcinoma treated by transarterial chemoembolisation (TACE) using Drug Eluting Beads. Implications for clinical practice and trial design.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Chemoembolization with doxorubicin-eluting beads for unresectable hepatocellular carcinoma: five-year survival analysis.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Benefit of initial resection of hepatocellular carcinoma followed by transplantation in case of recurrence: an intention-to-treat analysis.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Laparoscopic versus open liver resection for hepatocellular carcinoma: Case-matched study with propensity score matching
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Comparison of resection and ablation for hepatocellular carcinoma: a cohort study based on a Japanese nationwide survey
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Recent advances in the prevention of hepatocellular carcinoma recurrence
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Adjuvant immunotherapy with autologous cytokine-induced killer cells for hepatocellular carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prospective validation of ab initio liver transplantation in hepatocellular carcinoma upon detection of risk factors for recurrence after resection.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Liver transplantation for hepatocellular carcinoma: outcomes and novel surgical approaches
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Liver transplantation in patients with hepatocellular carcinoma across Milan criteria
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Liver Transplantation for Hepatocellular Carcinoma: A Model Including α-Fetoprotein Improves the Performance of Milan Criteria
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Total tumor volume and alpha-fetoprotein for selection of transplant candidates with hepatocellular carcinoma: A prospective validation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Squaring the circle of selection and allocation in liver transplantation for HCC: An adaptive approach.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Image-guided ablation of primary liver and renal tumours
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clinical outcomes of radiofrequency ablation, percutaneous alcohol and acetic acid injection for hepatocelullar carcinoma: a meta-analysis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Percutaneous cooled-probe microwave versus radiofrequency ablation in early-stage hepatocellular carcinoma: a phase III randomised controlled trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A randomized trial comparing radiofrequency ablation and surgical resection for HCC conforming to the Milan criteria
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinoma.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cost-effectiveness of hepatic resection versus percutaneous radiofrequency ablation for early hepatocellular carcinoma.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Treatment of intermediate-stage hepatocellular carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomised controlled trial of doxorubicin-eluting beads vs conventional chemoembolisation for hepatocellular carcinoma.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomized Trial of Hepatic Artery Embolization for Hepatocellular Carcinoma Using Doxorubicin-Eluting Microspheres Compared With Embolization With Microspheres Alone
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Brivanib as adjuvant therapy to transarterial chemoembolization in patients with hepatocellular carcinoma: A randomized phase III trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Sorafenib or placebo plus TACE with doxorubicin-eluting beads for intermediate stage HCC: The SPACE trial.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Sorafenib in combination with transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma (TACE 2): a randomised placebo-controlled, double-blind, phase 3 trial.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Field-practice study of sorafenib therapy for hepatocellular carcinoma: A prospective multicenter study in Italy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Postprogression survival of patients with advanced hepatocellular carcinoma: rationale for second-line trial design
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
GIDEON (Global Investigation of therapeutic DEcisions in hepatocellular carcinoma and Of its treatment with sorafeNib): second interim analysis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Sunitinib versus sorafenib in advanced hepatocellular cancer: results of a randomized phase III trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Brivanib versus sorafenib as first-line therapy in patients with unresectable, advanced hepatocellular carcinoma: results from the randomized phase III BRISK-FL study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
SEARCH: a phase III, randomized, double-blind, placebo-controlled trial of sorafenib plus erlotinib in patients with advanced hepatocellular carcinoma.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Linifanib versus Sorafenib in patients with advanced hepatocellular carcinoma: results of a randomized phase III trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Plasma biomarkers as predictors of outcome in patients with advanced hepatocellular carcinoma.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prognostic factors and predictors of sorafenib benefit in patients with hepatocellular carcinoma: Analysis of two phase III studies
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Early dermatologic adverse events predict better outcome in HCC patients treated with sorafenib.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Brivanib in patients with advanced hepatocellular carcinoma who were intolerant to sorafenib or for whom sorafenib failed: results from the randomized phase III BRISK-PS study.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of everolimus on survival in advanced hepatocellular carcinoma after failure of sorafenib: the EVOLVE-1 randomized clinical trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Ramucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib (REACH): a randomised, double-blind, multicentre, phase 3 trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clinical decision making and research in hepatocellular carcinoma: pivotal role of imaging techniques
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Modified RECIST (mRECIST) assessment for hepatocellular carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Immunological landscape and immunotherapy of hepatocellular carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2818%2930010-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S0140-6736(18)30010-2
1 reference
stated in
Europe PubMed Central
PubMed publication ID
29307467
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29307467%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 April 2020
PubMed publication ID
29307467
1 reference
stated in
Europe PubMed Central
PubMed publication ID
29307467
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29307467%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 April 2020
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit